Paper7586898
Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.
Stretcher BN. Clin Pharmacokinet, 1995. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection. Papers, record 7586898. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7586898
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| HIV Infections | Major topic |
| Aging | |
| Antineoplastic Agents | |
| Didanosine | |
| Drug Interactions | |
| Guidelines as Topic | |
| Humans | |
| Phosphorylation | |
| Racial Groups | |
| Sex Characteristics | |
| Stavudine | |
| Zalcitabine | |
| Zidovudine |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00000965 | The Effects of Zidovudine on the Blood of HIV-Infected Patients | Background |
Source ClinicalTrials.gov
References128
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8175673 | Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8175673 | PubMed |
| 2 | 2570186 | Probenecid and zidovudine metabolism. | Lancet | 1989 | https://conductscience.org/library/papers/2570186 | PubMed |
| 3 | 1988507 | Pharmacokinetic disposition of zidovudine during pregnancy. | J Infect Dis | 1991 | https://conductscience.org/library/papers/1988507 | PubMed |
| 4 | 8097711 | Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine. | Drug Metab Dispos | 1993 | https://conductscience.org/library/papers/8097711 | PubMed |
| 5 | 2663302 | Clinical pharmacokinetics of zidovudine. An overview of current data. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2663302 | PubMed |
| 6 | 1895207 | Canadian multicenter azidothymidine trial: AZT pharmacokinetics. | J Acquir Immune Defic Syndr (1988) | 1991 | https://conductscience.org/library/papers/1895207 | PubMed |
| 7 | 1510405 | Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1510405 | PubMed |
| 8 | 1492005 | Comparative pharmacokinetics of zidovudine in healthy volunteers and in patients with AIDS with and without hepatic disease. | Pharmacotherapy | 1992 | https://conductscience.org/library/papers/1492005 | PubMed |
| 9 | 8366182 | Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation. | J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8366182 | PubMed |
| 10 | 1346807 | The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals. | J Acquir Immune Defic Syndr (1988) | 1992 | https://conductscience.org/library/papers/1346807 | PubMed |
| 11 | 1328267 | High-performance liquid chromatographic determination of 2',3'-didehydro-3'-deoxythymidine, a new anti-human immunodeficiency virus agent, in human plasma and urine. | J Chromatogr | 1992 | https://conductscience.org/library/papers/1328267 | PubMed |
| 12 | 8096373 | CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8096373 | PubMed |
| 13 | 8254464 | Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. | J Acquir Immune Defic Syndr (1988) | 1993 | https://conductscience.org/library/papers/8254464 | PubMed |
| 14 | 1720152 | Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction. | J Infect Dis | 1991 | https://conductscience.org/library/papers/1720152 | PubMed |
| 15 | 1686178 | The association of clinical conditions and serologic tests with CD4+ lymphocyte counts in HIV-infected subjects without AIDS. | AIDS | 1991 | https://conductscience.org/library/papers/1686178 | PubMed |
| 16 | 2293412 | In vitro measurement of phosphorylated zidovudine in peripheral blood leucocytes. | Ther Drug Monit | 1990 | https://conductscience.org/library/papers/2293412 | PubMed |
| 17 | 1379914 | Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection. | Drugs | 1992 | https://conductscience.org/library/papers/1379914 | PubMed |
| 18 | 2159302 | Cellular pharmacology of 2',3'-didehydro-2',3'-dideoxythymidine (D4T) in human peripheral blood mononuclear cells. | Biochem Pharmacol | 1990 | https://conductscience.org/library/papers/2159302 | PubMed |
| 19 | 2053945 | A reduced dose of zidovudine in patients with AIDS. | N Engl J Med | 1991 | https://conductscience.org/library/papers/2053945 | PubMed |
| 20 | 1671651 | Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. | BMJ | 1991 | https://conductscience.org/library/papers/1671651 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 17694300 | Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART. | Eur J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17694300 | PubMed |
| 17638393 | Nucleoside and nucleotide reverse transcriptase inhibitors in children. | Clin Drug Investig | 2007 | https://conductscience.org/library/papers/17638393 | PubMed |
| 16122281 | Pharmacokinetics of antiretroviral therapy in HIV-1-infected children. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/16122281 | PubMed |
| 9100148 | AIDS clinical trials. Is there access for all? | J Gen Intern Med | 1997 | https://conductscience.org/library/papers/9100148 | PubMed |
| 8861550 | Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection. | Drugs | 1996 | https://conductscience.org/library/papers/8861550 | PubMed |
| 8743337 | Drug interactions with antiviral drugs. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8743337 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7586898
GET https://conductscience.org/api/papers/v1/7586898/references?page=2